According to Royalty Pharma's latest financial reports the company's current revenue (TTM) is $2.35 B. In 2022 the company made a revenue of $2.23 B a decrease over the years 2021 revenue that were of $2.28 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.35 B | 5.24% |
2022 | $2.23 B | -2.28% |
2021 | $2.28 B | 7.87% |
2020 | $2.12 B | 16.98% |
2019 | $1.81 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $40.10 B | 1,603.46% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 1,349.28% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $0.48 B | -79.32% | ๐บ๐ธ USA |